In addition, it has been reported that inhibition of the PI3K/Akt/mammalian target of rapamycin (mTOR) pathway by apigenin enhances Bax expression and suppresses Bcl-2 expression and tumor cell growth in cisplatin-resistant human colorectal cancer cells [44]. Here, MTOR is linked to colorectal cancer.